HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Sanjay Misra Selected Research

Polytetrafluoroethylene (Teflon)

1/2010Evolution of shear stress, protein expression, and vessel area in an animal model of arterial dilatation in hemodialysis grafts.
8/2009Wall shear stress measurement using phase contrast magnetic resonance imaging with phase contrast magnetic resonance angiography in arteriovenous polytetrafluoroethylene grafts.
1/2009Adventitial transplantation of blood outgrowth endothelial cells in porcine haemodialysis grafts alleviates hypoxia and decreases neointimal proliferation through a matrix metalloproteinase-9-mediated pathway--a pilot study.
10/2008Fetuin-A expression in early venous stenosis formation in a porcine model of hemodialysis graft failure.
2/2008Increased expression of hypoxia-inducible factor-1 alpha in venous stenosis of arteriovenous polytetrafluoroethylene grafts in a chronic renal insufficiency porcine model.
2/2008Expression of hypoxia inducible factor-1 alpha, macrophage migration inhibition factor, matrix metalloproteinase-2 and -9, and their inhibitors in hemodialysis grafts and arteriovenous fistulas.
1/2003Vascular brachytherapy for hemodialysis vascular access dysfunction: exploring an unmet clinical need.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Sanjay Misra Research Topics

Disease

21Pathologic Constriction (Stenosis)
02/2014 - 01/2003
12Renal Artery Obstruction (Renal Artery Stenosis)
08/2013 - 02/2003
11Anoxia (Hypoxia)
02/2014 - 02/2008
10Hyperplasia
02/2014 - 01/2003
9Chronic Renal Insufficiency
08/2012 - 10/2006
8Arteriovenous Fistula
02/2014 - 02/2008
5Fistula
02/2014 - 08/2004
4Thrombosis (Thrombus)
04/2012 - 01/2003
3Ischemia
11/2013 - 11/2011
3Hypertension (High Blood Pressure)
08/2013 - 11/2008
3Neointima
06/2010 - 01/2003
3Infarction
01/2010 - 02/2003
2Wounds and Injuries (Trauma)
02/2014 - 02/2004
2Kidney Diseases (Kidney Disease)
03/2013 - 12/2011
2Fibrosis (Cirrhosis)
01/2013 - 12/2011
2Hemorrhage
11/2012 - 04/2012
2Neoplasms (Cancer)
04/2012 - 04/2011
1Aneurysm (Aneurysms)
12/2015
1Endoleak
12/2015
1Peripheral Arterial Disease
04/2015
1Polyarteritis Nodosa (Periarteritis Nodosa)
12/2014
1Vasculitis (Vasculitides)
12/2014
1Glomerulonephritis
12/2014
1Chronic Kidney Failure (Chronic Renal Failure)
01/2014
1Abdominal Aortic Aneurysm
01/2013
1Esophageal and Gastric Varices (Esophageal Varices)
11/2012
1Hyperlipidemias (Hyperlipidemia)
05/2012
1Myocardial Infarction
04/2012
1Hematuria
04/2012
1Abscess
04/2012
1Pneumonia (Pneumonitis)
04/2012
1Infection
04/2012
1Lung Injury
01/2012
1Acute Lung Injury
01/2012
1Edema
01/2012
1Pulmonary Edema
01/2012
1Heart Failure
11/2011
1Renal Insufficiency (Renal Failure)
08/2010
1Cholesterol Embolism
09/2009
1Acute Kidney Injury (Acute Renal Failure)
11/2008

Drug/Important Bio-Agent (IBA)

7glucuronyl glucosamine glycan sulfate (Vessel)IBA
02/2014 - 02/2008
7Polytetrafluoroethylene (Teflon)FDA Link
01/2010 - 01/2003
6OxygenIBA
08/2013 - 04/2008
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2014 - 05/2008
5Tissue Inhibitor of Metalloproteinase-1IBA
12/2011 - 02/2008
5Matrix Metalloproteinase 2 (Gelatinase A)IBA
08/2010 - 12/2005
3deoxyhemoglobinIBA
08/2013 - 04/2008
3Tissue Inhibitor of Metalloproteinase-2IBA
07/2009 - 04/2008
3Proteins (Proteins, Gene)IBA
02/2009 - 02/2008
3progelatinaseIBA
05/2008 - 02/2008
2Small Interfering RNA (siRNA)IBA
02/2014 - 01/2014
2CytokinesIBA
01/2014 - 08/2013
2Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
08/2010 - 05/2008
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
08/2010 - 05/2008
2Tissue Inhibitor of Metalloproteinases (TIMP)IBA
08/2010 - 02/2008
2Phenobarbital (Luminal)FDA Link
08/2009 - 05/2008
2alpha-Fetoproteins (AFP)IBA
02/2009 - 10/2008
2Matrix MetalloproteinasesIBA
04/2008 - 02/2008
2CreatinineIBA
10/2006 - 02/2003
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
12/2014
1Caspase 3 (Caspase-3)IBA
02/2014
1GadoliniumIBA
11/2013
1Liposomes (Liposome)IBA
11/2013
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
08/2013
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
08/2013
1LipocalinsIBA
08/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2013
1Biological Markers (Surrogate Marker)IBA
08/2013
1Simvastatin (Zocor)FDA LinkGeneric
08/2013
1Angiotensin Receptors (Angiotensin II Receptor)IBA
08/2013
1GelatinasesIBA
08/2013
1tetrachloroisophthalonitrile (Bravo)IBA
03/2013
1Dopamine (Intropin)FDA LinkGeneric
01/2012
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2012
1salicylhydroxamic acid (SHAM)IBA
01/2012
1Peroxidase (Myeloperoxidase)IBA
01/2012
1CollagenIBA
06/2010
1Fibronectins (Fibronectin)IBA
06/2010
1SodiumIBA
04/2010
1ReninIBA
04/2010
1AngiotensinsIBA
04/2010
1CholesterolIBA
09/2009
1LactoferrinIBA
02/2009

Therapy/Procedure

18Renal Dialysis (Hemodialysis)
02/2014 - 01/2003
17Transplants (Transplant)
12/2015 - 01/2003
15Stents
12/2015 - 02/2003
5Drug-Eluting Stents
04/2015 - 02/2008
5Embolic Protection Devices
08/2012 - 11/2008
4Angioplasty (Angioplasty, Transluminal)
04/2015 - 08/2004
2Laparoscopic Cholecystectomy
01/2008 - 02/2004
1Balloon Angioplasty
04/2015
1Surgical Splenorenal Shunt (Splenorenal Shunt)
11/2012
1Catheters
10/2012
1Amputation
05/2012
1Urinary Diversion (Ileal Conduit)
04/2012
1Nephrectomy
12/2011
1Ligation
12/2011
1Semiconductor Lasers
04/2011
1Endovascular Procedures
11/2009
1Transplantation (Transplant Recipients)
01/2009